ES8402810A1 - Procedimiento para preparar compuestos inhibidores de alil aminamonoamina oxidasa. - Google Patents

Procedimiento para preparar compuestos inhibidores de alil aminamonoamina oxidasa.

Info

Publication number
ES8402810A1
ES8402810A1 ES512699A ES512699A ES8402810A1 ES 8402810 A1 ES8402810 A1 ES 8402810A1 ES 512699 A ES512699 A ES 512699A ES 512699 A ES512699 A ES 512699A ES 8402810 A1 ES8402810 A1 ES 8402810A1
Authority
ES
Spain
Prior art keywords
integer
hydrogen
formula
phenyl
mao inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES512699A
Other languages
English (en)
Spanish (es)
Other versions
ES512699A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merrell Toraude et Cie
Original Assignee
Merrell Toraude et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Toraude et Cie filed Critical Merrell Toraude et Cie
Publication of ES8402810A1 publication Critical patent/ES8402810A1/es
Publication of ES512699A0 publication Critical patent/ES512699A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/62Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40Halogenated unsaturated alcohols
    • C07C33/46Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • C07C33/48Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts with unsaturation outside the aromatic rings
    • C07C33/483Monocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40Halogenated unsaturated alcohols
    • C07C33/46Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • C07C33/48Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts with unsaturation outside the aromatic rings
    • C07C33/486Polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09Geometrical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Treatment Of Sludge (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
ES512699A 1981-06-01 1982-05-31 Procedimiento para preparar compuestos inhibidores de alil aminamonoamina oxidasa. Granted ES512699A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/268,555 US4454158A (en) 1981-06-01 1981-06-01 Allyl amine MAO inhibitors

Publications (2)

Publication Number Publication Date
ES8402810A1 true ES8402810A1 (es) 1984-03-01
ES512699A0 ES512699A0 (es) 1984-03-01

Family

ID=23023513

Family Applications (4)

Application Number Title Priority Date Filing Date
ES512699A Granted ES512699A0 (es) 1981-06-01 1982-05-31 Procedimiento para preparar compuestos inhibidores de alil aminamonoamina oxidasa.
ES523875A Expired ES8503639A1 (es) 1981-06-01 1983-07-05 Procedimiento para preparar compuestos inhibidores de alil amina monoamina oxidasa. desglose de la patente de invencion n 512.699
ES523873A Granted ES523873A0 (es) 1981-06-01 1983-07-05 Procedimiento para preparar compuestos inhibidores de alil amina monoamina oxidasa, especialmente fluoralilaminas.
ES523874A Expired ES8503638A1 (es) 1981-06-01 1983-07-05 Procedimiento para preparar compuestos inhibidores de alil amina monoamina oxidasa para la composicion de productos farmaceuticos.

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES523875A Expired ES8503639A1 (es) 1981-06-01 1983-07-05 Procedimiento para preparar compuestos inhibidores de alil amina monoamina oxidasa. desglose de la patente de invencion n 512.699
ES523873A Granted ES523873A0 (es) 1981-06-01 1983-07-05 Procedimiento para preparar compuestos inhibidores de alil amina monoamina oxidasa, especialmente fluoralilaminas.
ES523874A Expired ES8503638A1 (es) 1981-06-01 1983-07-05 Procedimiento para preparar compuestos inhibidores de alil amina monoamina oxidasa para la composicion de productos farmaceuticos.

Country Status (18)

Country Link
US (1) US4454158A (OSRAM)
EP (1) EP0067105B1 (OSRAM)
JP (1) JPS5823649A (OSRAM)
KR (1) KR890002756B1 (OSRAM)
AT (1) ATE29875T1 (OSRAM)
AU (2) AU550607B2 (OSRAM)
CA (2) CA1187500A (OSRAM)
DE (1) DE3277371D1 (OSRAM)
DK (1) DK244282A (OSRAM)
ES (4) ES512699A0 (OSRAM)
GB (2) GB2100255B (OSRAM)
GR (1) GR78033B (OSRAM)
IE (1) IE53456B1 (OSRAM)
IL (2) IL65808A (OSRAM)
MX (1) MX9202950A (OSRAM)
NO (1) NO152837C (OSRAM)
NZ (1) NZ200644A (OSRAM)
ZA (1) ZA823633B (OSRAM)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699928A (en) * 1984-07-13 1987-10-13 Merrell Dow Pharmaceuticals Inc. Fluoroallylamine derivatives
NZ214698A (en) * 1984-12-31 1988-08-30 Merrell Dow Pharma Thiophene derivatives and pharmaceutical compositions containing such
NZ214697A (en) * 1984-12-31 1988-10-28 Merrell Dow Pharma B-methylene-2- and 3-furanethanamine and pharmaceutical compositions
US4703058A (en) * 1984-12-31 1987-10-27 Merrell Dow Pharmaceuticals Inc. β-methylene furanethanamines and use as anti-hypertensive agents
EP0224924B1 (en) * 1985-12-05 1992-01-22 Merrell Dow Pharmaceuticals Inc. Non-aromatic fluorallylamine mao inhibitors
US4650907A (en) * 1985-12-05 1987-03-17 Merrell Dow Pharmaceuticals Inc. Nonaromatic fluoroallylamine MAO inhibitors
US4822812A (en) * 1987-05-21 1989-04-18 Merrell Dow Pharmaceuticals Inc. β-(Fluoromethylene)-5-hydroxytryptophan and derivatives and their use as prodrugs for MAO inhibition
AR243493A1 (es) * 1987-06-16 1993-08-31 Merrell Dow Pharma Procedimiento para preparar (e)-2-(p-fluorfenetil)-3-fluoralilamina y sus sales farmaceuticamente aceptables, util como inhibidor de mao-b irreversible y activado por enzimas.
US4965288A (en) * 1988-02-25 1990-10-23 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4943593A (en) * 1988-02-25 1990-07-24 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5252608A (en) * 1988-02-25 1993-10-12 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5182297A (en) * 1988-02-25 1993-01-26 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
CA1338647C (en) * 1988-02-25 1996-10-15 Michael G. Palfreyman Inhibitors of lysyl oxidase
US5059714A (en) * 1988-02-25 1991-10-22 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5120764A (en) * 1988-11-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4981868A (en) * 1989-07-25 1991-01-01 Merrell Dow Pharmaceutical Pharmaceutically active 3-heteroaryl-2-fluoro-1-olefins
EP0814789B2 (en) * 1995-03-02 2008-01-09 R.P. Scherer Technologies, Inc. Pharmaceutical compositions comprising monoamine oxidase b inhibitors
EP2004166A2 (en) * 2006-03-31 2008-12-24 La Jolla Pharmaceutical Company Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
JP2009542768A (ja) * 2006-07-13 2009-12-03 ビーエーエスエフ ソシエタス・ヨーロピア 殺菌性アゾロピリミジン、それらの製造方法及び有害菌の防除のためのそれらの使用、並びにそれらを含む物質
WO2009055002A1 (en) * 2007-10-24 2009-04-30 La Jolla Pharmaceutical Company Combined inhibitors of cyclooxygenase and semicarbazide-sensitive amine oxidase (ssao) (vascular adhesion protein, vap-1)
NZ585528A (en) 2007-11-21 2012-08-31 Pharmaxis Ltd Haloallylamine inhibitors of ssao/vap-1 and uses therefor
EP2844637B1 (en) 2012-05-02 2018-03-28 Boehringer Ingelheim International GmbH Substituted 3-haloallylamine inhibitors of ssao and uses thereof
WO2015087094A1 (en) * 2013-12-10 2015-06-18 Semmelweis Egyetem New arylalkenylpropargylamine derivatives exhibiting neuroprotective action for the treatment of neurodegenerative diseases
WO2020024017A1 (en) 2018-08-03 2020-02-06 Pharmaxis Ltd. Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof
US12233056B2 (en) 2022-04-06 2025-02-25 Syntara Limited Lysyl oxidase inhibitors for treating myeloid malignancies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2343038A1 (de) * 1973-08-25 1975-03-06 Hoechst Ag 2,3-diaryl-3-halogenallylamine und verfahren zu ihrer herstellung
SE7809127L (sv) * 1978-08-30 1980-03-01 Claesson Alf Allenaminer

Also Published As

Publication number Publication date
ES8507461A1 (es) 1985-10-01
AU550607B2 (en) 1986-03-27
ES523874A0 (es) 1985-04-16
MX9202950A (es) 1992-07-01
US4454158A (en) 1984-06-12
ES523875A0 (es) 1985-04-16
IL65808A0 (en) 1982-08-31
GB2152039B (en) 1986-04-30
IL75829A0 (en) 1985-11-29
IL65808A (en) 1986-12-31
AU8423882A (en) 1983-02-03
NZ200644A (en) 1986-06-11
EP0067105A2 (en) 1982-12-15
ES8503639A1 (es) 1985-04-16
US4454158B1 (OSRAM) 1992-12-22
ES523873A0 (es) 1985-10-01
NO152837B (no) 1985-08-19
KR830010044A (ko) 1983-12-24
IE53456B1 (en) 1988-11-23
DK244282A (da) 1982-12-02
AU5180586A (en) 1986-06-12
KR890002756B1 (ko) 1989-07-27
JPH0422898B2 (OSRAM) 1992-04-20
CA1187500A (en) 1985-05-21
EP0067105A3 (en) 1984-02-22
ES8503638A1 (es) 1985-04-16
DE3277371D1 (en) 1987-10-29
CA1204759A (en) 1986-05-20
GR78033B (OSRAM) 1984-09-26
IE821246L (en) 1982-12-01
GB2152039A (en) 1985-07-31
AU576281B2 (en) 1988-08-18
NO821799L (no) 1982-12-02
ES512699A0 (es) 1984-03-01
EP0067105B1 (en) 1987-09-23
NO152837C (no) 1985-11-27
JPS5823649A (ja) 1983-02-12
GB8428858D0 (en) 1984-12-27
ATE29875T1 (de) 1987-10-15
GB2100255B (en) 1985-10-23
GB2100255A (en) 1982-12-22
ZA823633B (en) 1983-03-30

Similar Documents

Publication Publication Date Title
ES8402810A1 (es) Procedimiento para preparar compuestos inhibidores de alil aminamonoamina oxidasa.
NO812311L (no) Bronchospasmolytisk virksomme forbindelser og fremgangsmaate for deres fremstilling
KR900007406A (ko) 리실 옥시마제의 억제제
EP0176927A3 (en) Diazepine-containing pharmaceutical compositions having a platelet activating factor (paf)-antagonist action
NO951646D0 (no) Nye merkaptoacetylamid-bisykliske laktamderivater som er anvendbare som inhibitorer av enkefalinase og ACE
TW328089B (en) New azolidinediones as antihyperglycemic agents
DE69808326D1 (de) Azetidinonderivate zur behandlung von hcmv entzündungen
ES488387A1 (es) Procedimiento de preparacion de derivados condensados de pi-rrolidina
FI824407L (fi) Foerfarande foer framstaellning av vid behandling av magsaor anvaendbara pyrimidinderivat
ES449765A1 (es) Procedimiento para la preparacion de nuevas homoftalimidas.
GB1139135A (en) Aminoalkyl-substituted indanes and pharmaceutical compositions containing them
ES8305758A1 (es) "un procedimiento para la preparacion de 2-(1,4-benzodioxan-2-il-metil)-imidazolina".
DK0660821T3 (da) Ikke-metaboliserbare clomiphen-analoge til behandling af tamoxifen-resistente tumorer
SE7809127L (sv) Allenaminer
ES475787A1 (es) Procedimiento para la obtencion de derivados del acidos prostanoicos opticamente activo
ES422085A1 (es) Procedimiento para preparar amino-acilanilidas primarias.
ES459756A1 (es) Procedimiento para la obtencion de isoquinolinas.
GB1216170A (en) N-substituted aryl carbmates
KR910019971A (ko) 신규한 아미노 보호 그룹
ES472090A2 (es) Mejoras introducidas en el objeto de la patente principal n.451407 por:procedimiento para preparar derivados de amidoxi-ma